Acitretin (Teva Pharmaceuticals USA, Inc.)
Welcome to the PulseAid listing for the Acitretin drug offered from Teva Pharmaceuticals USA, Inc.. This Retinoid [EPC],Retinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA, Inc. |
NON-PROPRIETARY NAME: | Acitretin |
SUBSTANCE NAME: | ACITRETIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Retinoid [EPC],Retinoids [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2013-07-19 |
END MARKETING DATE: | 0000-00-00 |
Acitretin HUMAN PRESCRIPTION DRUG Details:
Item Description | Acitretin from Teva Pharmaceuticals USA, Inc. |
LABELER NAME: | Teva Pharmaceuticals USA, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/1) |
START MARKETING DATE: | 2013-07-19 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0093-1135_c451f00a-2c61-4afc-a220-000ed681c4ba |
PRODUCT NDC: | 0093-1135 |
APPLICATION NUMBER: | ANDA091455 |
Other ACITRETIN Pharmaceutical Manufacturers / Labelers: